Daniel Lynch Bluebird Bio, Inc. (BLUE) insider trading activity

BLUE Quotes by TradingView

Daniel Lynch is Director of bluebird bio, Inc.. Currently has a direct ownership of 7,959 shares of BLUE, which is worth approximately $3,740. The most recent transaction as insider was on Nov 11, 2021, when has been sold 0 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.96K
0% 3M change
0% 12M change
Total Value Held $3,740

DANIEL LYNCH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 11 2021
BUY
Other acquisition or disposition
-
0 Added 0.0%
7,959 Common Stock
Jun 15 2021
BUY
Grant, award, or other acquisition
-
4,353 Added 26.12%
12,312 Common Stock

Also insider at

SWTX
SpringWorks Therapeutics, Inc. Healthcare
Director
TSVT
2seventy bio, Inc. Healthcare
DL

Daniel Lynch

Director
Stamford,, CT

Track Institutional and Insider Activities on BLUE

Follow bluebird bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

News

Receive news related to bluebird bio, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLUE